Innate and Adaptive Immunity of the Eye

Advances in Organ Biology

Volumn 10, Issue , 2005, Pages 291-305

  Nissen, Mogens Holst ^a   Röpke, Carsten ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645941229     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(05)10011-1     Document Type: Review

References (59)

1. Apte R.S., Sinha D., Mayhew E., Wistow G.J., and Niederkorn J.Y. Cutting edge: Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 160 (1998) 5693-5696
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Bardenstein D.S., Cheyer C., Okada N., Morgan B.P., and Medof M.E. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues. Invest. Ophthalmol. Vis. Sci. 40 (1999) 519-524
5. Bora N.S., Gobleman C.L., Atkinson J.P., Pepose J.S., and Kaplan H.J. Differential expression of the complement regulatory proteins in the human eye. Invest. Ophthalmol. Vis. Sci. 34 (1993) 3579-3584
6. Catania A., Rajora N., Capsoni F., Minonzio F., Star R.A., and Lipton J.M. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17 (1996) 675-679
7. Chandler J.W., Leder R., Kaufman H.E., and Caldwell J.R. Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor. Invest. Ophthalmol. 13 (1974) 151-153
8. Faunce D.E., Sonoda K.H., and Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166 (2001) 313-321
9. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
10. Goslings W.R., Prodeus A.P., Streilein J.W., Carroll M.C., Jager M.J., and Taylor A.W. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest. Ophthalmol. Vis. Sci. 39 (1998) 989-995
11. Gregory M.S., Repp A.C., Holhbaum A.M., Saff R.R., Marshak-Rothstein A., and Ksander B.R. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J. Immunol. 169 (2002) 2727-2735
12. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
13. Haynes R.J., McElveen J.E., Dua H.S., Tighe P.J., and Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3026-3031
14. Haynes R.J., Tighe P.J., and Dua H.S. Antimicrobial defensin peptides of the human ocular surface. Br. J. Ophthalmol. 83 (1999) 737-741
15. Hernandez J.D., and Baum L.G. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 12 (2002) 127R-136R
16. Higazi A.A., Barghouti I.I., and Abu-Much R. Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils. A role for defensin. J. Biol. Chem. 270 (1995) 9472-9477
17. Higazi A.A., Ganz T., Kariko K., and Cines D.B. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J. Biol. Chem. 271 (1996) 17650-17655
18. Ishida K., Panjwani N., Cao Z., and Streilein J.W. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T cell activation by partially non-overlapping mechanisms. Ocul. Immunol. Inflamm. 11 (2003) 91-105
19. Jiang L.Q., and Streilein J.W. Immune privilege extended to allogeneic tumor cells in the vitreous cavity. Invest. Ophthalmol. Vis. Sci. 32 (1991) 224-228
20. Kaestel C.G., Jorgensen A., Nielsen M., Eriksen K.W., Odum N., Holst N.M., and Ropke C. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp. Eye Res. 74 (2002) 627-637
21. Kaplan H.J., and Streilein J.W. Do immunologically privileged sites require a functioning spleen?. Nature 251 (1974) 553-554
22. Kaplan H.J., and Streilein J.W. Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J. Immunol. 118 (1977) 809-814
23. Kaplan H.J., and Streilein J.W. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J. Immunol. 120 (1978) 689-693
24. Kennedy M.C., Rosenbaum J.T., Brown J., Planck S.R., Huang X., Armstrong C.A., and Ansel J.C. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J. Clin. Invest. 95 (1995) 82-88
25. Kezuka T., Sakai J., Usui N., Streilein J.W., and Usui M. Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. Arch. Ophthalmol. 119 (2001) 1044-1049
26. Lehmann O.J., Hussain I.R., and Watt P.J. Investigation of beta defensin gene expression in the ocular anterior segment by semiquantitative RT-PCR. Br. J. Ophthalmol. 84 (2000) 523-526
27. Liversidge J., McKay D., Mullen G., and Forrester J.V. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 149 (1993) 315-330
28. Masli S., Turpie B., Hecker K.H., and Streilein J.W. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J. Immunol. 168 (2002) 2264-2273
29. McClellan K.A. Mucosal defense of the outer eye. Surv. Ophthalmol. 42 (1997) 233-246
30. Molina H. The murine complement regulator Crry: New insights into the immunobiology of complement regulation. Cell Mol. Life Sci. 59 (2002) 220-229
31. Namba K., Kitaichi N., Nishida T., and Taylor A.W. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J. Leukoc. Biol. 72 (2002) 946-952
32. + DC1 precursors. Blood 101 (2003) 1453-1459
33. Rezai K.A., Semnani R.T., Farrokh-Siar L., Hamann K.J., Patel S.C., Ernest J.T., and van Seventer G.A. Human fetal retinal pigment epithelial cells induce apoptosis in allogenic T cells in a Fas ligand and PGE2 independent pathway. Curr. Eye Res. 18 (1999) 430-439
34. Sheibani N., Sorenson C.M., Cornelius L.A., and Frazier W.A. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor, and is modulated by hyperglycemia. Biochem. Biophys. Res. Commun. 267 (2000) 257-261
35. Skelsey M.E., Mellon J., and Niederkorn J.Y. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J. Immunol. 166 (2001) 4327-4333
36. Sohn J.H., Bora P.S., Suk H.J., Molina H., Kaplan H.J., and Bora N.S. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 9 (2003) 206-212
37. Sohn J.H., Kaplan H.J., Suk H.J., Bora P.S., and Bora N.S. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3492-3502
38. Sohn J.H., Kaplan H.J., Suk H.J., Bora P.S., and Bora N.S. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest. Ophthalmol. Vis. Sci. 41 (2000) 4195-4202
39. Sonoda K.H., Exley M., Snapper S., Balk S.P., and Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190 (1999) 1215-1226
40. Sonoda K.H., and Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32 (2002) 848-857
41. Streilein J.W. Regional immunity and ocular immune privilege. Chem. Immunol. 73 (1999) 11-38
42. Streilein J.W. Ocular immune privilege: The eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 74 (2003) 179-185
43. Streilein J.W. Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3 (2003) 879-889
44. Streilein J.W., Masli S., Takeuchi M., and Kezuka T. The eye's view of antigen presentation. Hum. Immunol. 63 (2002) 435-443
45. Streilein J.W., and Niederkorn J.Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 153 (1981) 1058-1067
46. Stuart P.M., Griffith T.S., Usui N., Pepose J., Yu X., and Ferguson T.A. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99 (1997) 396-402
47. Sugita S., and Streilein J.W. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 198 (2003) 161-171
48. Takeuchi M., Alard P., and Streilein J.W. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160 (1998) 1589-1597
49. Taylor A.W., Streilein J.W., and Cousins S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11 (1992) 1199-1206
50. Taylor A.W., Streilein J.W., and Cousins S.W. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153 (1994) 1080-1086
51. Taylor A.W., and Yee D.G. Somatostatin is an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2644-2649
52. Taylor A.W., Yee D.G., and Streilein J.W. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1372-1378
53. Wenkel H., Chen P.W., Ksander B.R., and Streilein J.W. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space. Invest. Ophthalmol. Vis. Sci. 40 (1999) 3202-3208
54. Wilbanks G.A., and Streilein J.W. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 71 (1990) 566-572
55. Wilbanks G.A., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J. Immunol. 146 (1991) 2610-2617
56. Yang P., Chen L., Zwart R., and Kijlstra A. Immune cells in the porcine retina: Distribution, characterization and morphological features. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1488-1492
57. Yang P., Das P.K., and Kijlstra A. Localization and characterization of immunocompetent cells in the human retina. Ocul. Immunol. Inflamm. 8 (2000) 149-157
58. Yoshida M., Kezuka T., and Streilein J.W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3862-3870
59. Yoshida M., Takeuchi M., and Streilein J.W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T cell activation in vitro by direct cell-to-cell contact. Invest. Ophthalmol. Vis. Sci. 41 (2000) 811-821